Results 11 to 20 of about 1,726 (212)

New and emerging therapies in cutaneous T-cell lymphoma [PDF]

open access: yesDermatology Reports
Mycosis Fungoides (MF) is the most common cutaneous T-cell lymphoma that typically presents in the early phase as inflammatory erythematous patches or plaques, with epidermotropism as the histopathological hallmark of the disease.
Gabriele Roccuzzo   +4 more
doaj   +2 more sources

EXTRACORPOREAL PHOTOCHEMOTHERAPY IN THE TREATMENT OF TYPICAL AND ATYPICAL LICHEN PLANUS RUBRUM

open access: diamondAlʹmanah Kliničeskoj Mediciny, 2016
Background: Lichen planus rubrum (LPR) belongs to the group of papulosquamous dermatoses. Pathophysiology of this most common lichenic dermatosis is related to autoimmune destruction of basal keratinocytes.
A. V. Molochkov   +2 more
doaj   +3 more sources

Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy. [PDF]

open access: bronzeBlood, 2010
Berger C   +15 more
europepmc   +2 more sources

348 Immunomodulatory Effects of Extracorporeal Photochemotherapy in Systemic Sclerosis [PDF]

open access: goldWorld Allergy Organ J, 2012
Zeher M   +6 more
europepmc   +2 more sources

Real-World Safety Data From the World Apheresis Association Registry for the Spectra Optia Apheresis System. [PDF]

open access: yesJ Clin Apher
ABSTRACT In this study we analyzed 12 years of adverse events, (AE) data from the World Apheresis Association, (WAA) Registry specific to the Spectra Optia Apheresis System. We queried WAA Registry data, (2012–2023) on apheresis procedures performed exclusively on the Spectra Optia Apheresis System.
Haubner A   +13 more
europepmc   +2 more sources

Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis

open access: goldClinical Immunology, 2011
The aim of this study was to evaluate the clinical and immunomodulatory effects of extracorporeal photochemotherapy (ECP) in systemic sclerosis (SSc). We enrolled 16 patients with diffuse cutaneous SSc, who received 12 ECP treatments in total. After ECP treatments, the dermal thickness reduced and the mobility of joints improved.
Gábor Papp   +6 more
openalex   +4 more sources

Extracorporeal photochemotherapy for steroid-refractory graft-versus-host disease in low-weight pediatric patients. Immunomodulatory effects and clinical outcome

open access: goldHaematologica, 2008
Marta González-Vicent   +5 more
doaj   +3 more sources

Use of Extracorporeal Photopheresis Treatment Over Time (2001-2023) in Alberta, Canada: A Retrospective Cohort Study. [PDF]

open access: yesHealth Sci Rep
Health Science Reports, Volume 8, Issue 10, October 2025.
Girard L   +7 more
europepmc   +2 more sources

Mode of action, indications and recommendations on extracorporeal photopheresis (ECP)

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 21, Issue 11, Page 1369-1380, November 2023., 2023
Summary Extracorporeal photopheresis (ECP) has gained importance in the treatment of several diseases. Initially introduced as a new therapeutic modality for the treatment of patients with cutaneous T‐cell lymphoma, the indications for the use of ECP have expanded to include hematology and transplantation immunology.
Ara Cho   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy